Form 4: Teleflex Director Candace H. Duncan Reports Stock and Option Awards

Director Candace H. Duncan reports the acquisition of common stock and stock options in Teleflex Inc. on May 7, 2024.

Summary

• On May 7, 2024, Candace H. Duncan, a director of Teleflex Inc. (TFX), reported the acquisition of 649 shares of common stock at $0 and 1,349 stock options with an exercise price of $201.52.
• The common stock was received as a restricted stock unit award under the company's 2023 Stock Incentive Plan.
• The stock options vest on May 7, 2025, or earlier if Duncan does not stand for re-election to the board at the 2025 annual meeting, provided that meeting is held at least 50 weeks after the 2024 annual meeting.
• Following these transactions, Duncan directly owns 4,706.9377 shares of common stock and 1,349 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard compensation practices and aligns director interests with shareholders. There are no indications of negative performance or concerns.

Positives

• The grant of restricted stock units and stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the board.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting conditions of the stock options and restricted stock units.

Industry Context

This filing is a routine disclosure of insider transactions, common for publicly traded companies to ensure transparency and compliance with SEC regulations. It reflects standard compensation practices for directors.

Comparison to Industry Standards

• Stock option grants to board members are a common practice across the medical device industry, used to align director compensation with company performance.
• Companies like Medtronic and Boston Scientific also utilize stock options and restricted stock units as part of their director compensation packages.
• The vesting schedules and exercise prices are generally in line with industry norms, designed to incentivize long-term value creation.

Stakeholder Impact

• The stock and option awards align the director's interests with those of the shareholders, incentivizing decisions that increase shareholder value.

Key Dates